Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine in Ulcerative Colitis
NCT07064707Phase 2Recruiting
- Sponsor
- Alexandria University
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rupatadine in ulcerative colitis (UC), sponsored by Alexandria University. Started Jul 2025; status: recruiting.
02
Drugs
rupatadine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07064707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064707.